Merck is investing $2.9 billion to expand its vaccine and medicine manufacturing operations in Montgomery County, Pennsylvania, by the end of 2030. Gov. Josh Shapiro and DCED Secretary Rick Siger announced the deal Wednesday, along with $5 million in state support.
Robots in Lab Coats: The centerpiece is ADVANCE, a robotics and AI-enabled drug R&D facility on Merck’s West Point campus. Merck CEO Rob Davis called it “the future of clinical development at Merck.”
$550 million of the total goes to ADVANCE and the nearby Springhouse Innovation Park (SHIP) R&D facility.
Shapiro and Siger helped cut the ribbon on ADVANCE during Wednesday’s announcement.
Plenty of Runway: That ribbon marks one facility, not the whole package. Merck’s full commitment runs through the end of 2030, which leaves more than four years for the rest of the expansion to take shape.
Not Exactly a Corner Pharmacy: West Point makes more than 200 million doses of vaccines a year, according to the governor’s office.
The State’s Side Dish: Merck received a funding proposal from DCED for a $5 million Redevelopment Assistance Capital Program (RACP) grant tied to the first West Point projects. That works out to roughly 0.17% of Merck’s commitment.
Merck is paying for the party, and the Commonwealth brought the chips.
Pennsylvania’s Pill Pipeline:
About 3,900 companies
More than 110,000 Pennsylvanians employed
$73 billion contributed directly to the economy
The office also credits Shapiro with landing more than $43 billion in private sector investment and nearly 29,000 new jobs since he took office.
Head Count Pending: Shapiro said Merck’s expansion will create new opportunities for “thousands of Pennsylvanians,” but the release gives no job figure for this project. That’s the number to watch between now and 2030.
🥾Want to advertise in TheJobWalk? Learn More🥾
